Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Transcatheter Pulmonary Valve Replacement for Right Ventricular Outflow Tract Conduit Dysfunction After the Ross Procedure

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Ten-Year Trends of Clinicopathologic Features and Surgical Treatment of Lung Cancer in China

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Intrathoracic Splenosis Without Clinical Evidence of Diaphragmatic Rupture

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Exploring Shared Mental Models of surgical teams in Video-Assisted Thoracoscopic Surgery lobectomy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Postmarket Experience With HeartMate 3 Left Ventricular Assist Device: 30-Day Outcomes From the ELEVATE Registry

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Cardiovascular complications in patients with total cavopulmonary connection: A nationwide cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Intravascular iliac artery lithotripsy to enable transfemoral thoracic endovascular aortic repair

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Feasibility and safety of transcaval transcatheter aortic valve implantation: a multicentre European registry

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Impact of implant depth on hydrodynamic function of the ALLEGRA bioprosthesis in valve-in-valve interventions

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Matthew J Gillespie
  • Doff B McElhinney
  • Jacqueline Kreutzer
  • William E Hellenbrand
  • Howaida El-Said
  • Peter Ewert
  • John F Rhodes
  • Lars Søndergaard
  • Thomas K Jones
Vis graf over relationer

BACKGROUND: Right ventricular outflow tract (RVOT) conduit dysfunction is a limitation of the Ross procedure. Transcatheter pulmonary valve replacement (TPVR) could alter the impact of conduit dysfunction and the risk-benefit balance for the Ross procedure.

METHODS: Retrospective review of databases from 3 prospective Melody TPV (Medtronic Inc, Minneapolis, MN) trials.

RESULTS: Among 358 patients who were catheterized with the intent to implant a Melody TPV for RVOT conduit stenosis or regurgitation (PR) as part of 3 prospective multicenter studies, 67 (19%) had a prior Ross procedure. Of these, 56 (84%) received a Melody valve; in 5 of the 11 patients who did not, the implant was aborted due to concern for coronary artery compression, and 1 implanted patient required emergent surgery for left coronary compression. The RVOT gradient decreased from a median 38 mm Hg to 13.5 mm Hg (p < 0.001). There was no or trivial PR in all but 4 patients, in whom it was mild. At a median follow-up of 4.0 years, 1 patient died from sepsis. Twelve patients underwent 14 transcatheter (n = 8) or surgical (n = 6) TPV reinterventions for obstruction with stent fracture (n = 9), endocarditis with conduit obstruction (n = 3), or reoperation (n = 2). Freedom from TPV explant was 89% ± 5% at 4 years. Among patients who did not undergo reintervention for obstruction, there was no change in RVOT gradient over time, and all but 1 patient had mild or less PR at last follow-up.

CONCLUSIONS: The TPVR with the Melody valve provides acceptable early outcomes and durable valve function in the majority of Ross patients. Recurrent RVOT obstruction associated with stent fracture was the main reason for reintervention. Coronary compression is not uncommon in Ross patients and should be assessed prior to TPVR.

OriginalsprogEngelsk
TidsskriftThe Annals of thoracic surgery
Vol/bind100
Udgave nummer3
Sider (fra-til)996-1002; discussion 1002-3
ISSN0003-4975
DOI
StatusUdgivet - sep. 2015

ID: 46182011